Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:11:53.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:52:23.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The earlier notice Revision: v3.4.1 and related government funding/operating status notices were removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:44.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status and a new revision tag (v3.4.1) were added, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:18:29.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    UI and metadata updates include showing the glossary and adding the QC-related label 'Last Update Submitted that Met QC Criteria' and the revision tag 'Revision: v3.4.0'. The earlier QC label, 'No FEAR Act data,' and 'Revision: v3.3.4' text are removed or updated accordingly.
    Difference
    0.2%
    Check dated 2026-01-28T04:56:33.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.